1 Vistagen Therapeutics Inc Receivables Turnover Ratio (VTGN), from the first quarter 2026 to the first quarter 2026 current and historic results, rankings and more - CSIMarket

Company Name, Ticker, Suppliers, else..

Growth Rates

Profitability

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

• Sales per Employee

• Income per Employee

• Inventory Turnover

• Asset Turnover

• Receivables Turnover

Dividend Comparisons

Vistagen Therapeutics Inc (NASDAQ: VTGN)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Vistagen Therapeutics Inc Accounts Receivables Turnover Ratio from the first quarter 2026 to the first quarter 2026

Quarterly Results, Trends, Rankings, Statistics

According to Vistagen Therapeutics Inc Balance Sheet, in the first quarter 2026, company has not reported any Accounts receivable.
See Vistagen Therapeutics Inc Balance Sheet

If we take a look into Healthcare sector 513 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 3583 to 3746.

What is Receivable Turnover Ratio?
What is Vistagen Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VTGN Receivables Turnover Ratio	(Jun 30 2026) I. Quarter	(Mar 31 2026) IV. Quarter	(Dec 31 2025) III. Quarter	(Sep 30 2025) II. Quarter	(Jun 30 2025) I. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	504.92 %	-	29.49 %	40.98 %	190.48 %
Receivable Turnover Ratio (TTM)	-	-	-	-	-
VTGN's Total Ranking	# 3746	# 3583	# 0	# 3281	# 3457
Accounts Receivable average collection period days	-	-	-	-	-
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	218.1 %	53.14 %	17.44 %	5.74 %	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 176
Healthcare Sector	# 514
Overall Market	# 3746

Receivable Turnover Ratio Statistics
High	Average	Low
1.66	0.15	-0.01
(Jun 30 2012)		(Jun 30 2023)

VTGN Company Profile • Back to VTGN Efficiency Comparisons • Compare VTGN Receivables Turnover Ratio to its Competitors

Financial Statements
Vistagen Therapeutics Inc 's Accounts Receivable	$ 0 Millions	Visit VTGN's Balance sheet
Vistagen Therapeutics Inc 's Sales TTM	$ 3 Millions	Visit VTGN's Income Statement
Sources of VTGN's Revenues		Visit VTGN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VTGN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VTGN's Growth Rates	VTGN's Roa	VTGN's Inventory Turnover Ratio	VTGN's Dividend Comparisons
VTGN's Profitability Ratios	VTGN's Roi	VTGN's Asset Turnover Ratio	VTGN's Dividend Growth
VTGN's Valuation Ratios	VTGN's Roe	VTGN's Financial Strength Ratios	VTGN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Jun 30 2026

Receivable at quarter ending Jun 30 2026

Date modified: 2026-08-15T21:51:31+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.